Business
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 9, 2018
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 9, 2018.
About this update from Rennova Health, Inc.
[{"type":"text","content":"\n\n WEST PALM BEACH, Fla, May 01, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, announces the postponement of its Special Meeting of Stockholders to May 9, 2018 at 11:00 a.m. Eastern time at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of March 12, 2018 remains unchanged. This Special Meeting was originally scheduled for April 18, 2018, and was subsequently postponed to May 2, 2018.\n “Stockholder approval of the proposed increase in authorized common shares plus the ability to enact a reverse stock split is critical for the company going forward,” stated Seamus Lagan, President and Chief Executive Officer of Rennova adding “Should any of the company’s convertible debt or preferred stock holders elect to exercise or convert their debt or preferred shares, the company currently does not have sufficient shares to meet those obligations. If the obligations cannot be met the holders of the convertible debt and preferred shares could benefit from ownership of the assets of the Company at the expense of stockholders”. “Our Board of Directors has recommended that our shareholders support the approvals requested and believe that to do so is in the best interest of all shareholders” noted Mr. Lagan. If you have already voted and wish to change your vote or if you are ready to vote your shares now, please call our proxy solicitor, Advantage Proxy toll free at 1-877-870-8565 for assistance. The Special Meeting is for the following purposes: 1. To approve an amendment to our certificate of incorporation, as amended, to effect a reverse stock split of all of the outstanding shares of our common stock, par value $0.01 per share, at a specific ratio within a range of 1-for-50 to 1-for-300, and to grant authorization to our Board of Directors to determine, in its discretion, the specific ratio and timing of the reverse stock split any time before March 1, 2019, subject to the Board of Directors’ discretion to abandon such amendment; 2. To approve an a...